Jun Ma
Physician Assistant • Flushing, NY
4235 Main St Ste 3h
Flushing, NY 113553969
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on March 16, 2020; this date does not establish years in practice.
-
Published CMS data list 1,926 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Anastrozole — 350 prescription fills, including refills.
- Alendronate Sodium — 195 prescription fills, including refills.
- Diphenhydramine Hcl — 139 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 39 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 85% of clinicians listed under Physician Assistant in Flushing, NY (2024, 104 clinicians with data). Median for this group: 119. Middle half: 32 to 438.
More Part D prescriptions than 85% of clinicians listed under Physician Assistant in New York (2024, 6,800 clinicians with data). Median for this group: 172. Middle half: 46 to 640.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 116 in 2020 to 1,926 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
4235 Main St Ste 3h
Flushing, NY 113553969
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Physician Assistant: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
2,088 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$5,549,976 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,145.65 across 38 records.
By nature of payment
- Food and Beverage: $851.66 across 34 records.
- Education: $293.99 across 4 records.
Reporting-company totals (3 largest of 19)
- Janssen Pharmaceuticals, Inc: $348.89 across 8 records.
- Merck Sharp & Dohme LLC: $130.20 across 5 records.
- Daiichi Sankyo Inc.: $114.62 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2020
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Jun Ma has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Jun Ma as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Flushing and New York
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 85% of clinicians listed under Physician Assistant in Flushing, NY (2024, 104 clinicians with data). Median for this group: 119. Middle half: 32 to 438.
More Part D prescriptions than 85% of clinicians listed under Physician Assistant in New York (2024, 6,800 clinicians with data). Median for this group: 172. Middle half: 46 to 640.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Physician Assistant in Flushing, NY (2024, 104 clinicians with data). Median for this group: $1,594. Middle half: $237 to $49,223.
A higher Part D drug cost than 95% of clinicians listed under Physician Assistant in New York (2024, 6,800 clinicians with data). Median for this group: $2,860. Middle half: $381 to $63,975.
279 active clinicians are listed under Physician Assistant with a practice address in Flushing, NY (15,558 in New York).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Flushing
3.6% of these 279 clinicians have the CMS telehealth indicator.
32.3% of these 279 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 1560% from 116 in 2020 to 1,926 in 2024.
- 2020: 116
- 2021: 358
- 2022: 346
- 2023: 1,194
- 2024: 1,926
-
30-day fills
30-day fills increased 1700% from 116 in 2020 to 2,088 in 2024.
- 2020: 116
- 2021: 358
- 2022: 379
- 2023: 1,312
- 2024: 2,088
-
Part D drug cost
Part D drug cost increased 622% from $769,008 in 2020 to $5,549,976 in 2024.
- 2020: $769,008
- 2021: $1,961,366
- 2022: $1,259,440
- 2023: $1,159,990
- 2024: $5,549,976
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $198.95 in 2021 to $1,145.65 in 2025.
- 2021: $198.95
- 2022: $1,033.02
- 2023: $2,218.44
- 2024: $1,566.67
- 2025: $1,145.65
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 38 records totaling $1,145.65.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
RYBREVANT | General | $125.00 |
| Janssen Pharmaceuticals, Inc |
Education
In-kind items and services
|
DARZALEX | General | $83.00 |
| Daiichi Sankyo Inc. |
Education
In-kind items and services
|
Enhertu | General | $77.99 |
| Janssen Pharmaceuticals, Inc |
Education
In-kind items and services
|
ERLEADA | General | $68.00 |
| Incyte Corporation |
Education
Cash or cash equivalent
|
— | General | $65.00 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
SARCLISA | General | $30.21 |
| Eisai Inc. |
Food and Beverage
In-kind items and services
|
Lenvima | General | $29.86 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TALVEY | General | $28.60 |
| Eisai Inc. |
Food and Beverage
In-kind items and services
|
Lenvima | General | $28.36 |
| Ipsen Biopharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
Onivyde | General | $27.79 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
KEYTRUDA | General | $27.61 |
| Deciphera Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
QINLOCK | General | $27.34 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
KEYTRUDA | General | $27.23 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
FRUZAQLA | General | $27.15 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TECVAYLI | General | $25.79 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
KEYTRUDA | General | $25.70 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
KEYTRUDA | General | $25.57 |
| Genmab U.S., Inc. |
Food and Beverage
In-kind items and services
|
Tivdak | General | $25.38 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
ENHERTU | General | $24.57 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $24.32 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
KEYTRUDA | General | $24.09 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
KISQALI | General | $24.01 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
SCEMBLIX | General | $22.65 |
| Daiichi Sankyo Inc. |
Food and Beverage
In-kind items and services
|
DATROWAY | General | $22.52 |
| Geron Corporation |
Food and Beverage
In-kind items and services
|
RYTELO | General | $22.03 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Anastrozole | Anastrozole | 350 | 12,990 | $2,582.64 | 71 |
| Alendronate Sodium | Alendronate Sodium | 195 | 6,140 | $652.15 | 41 |
| Diphenhydramine Hcl | Diphenhydramine Hcl | 139 | 3,120 | $140.01 | 21 |
| Revlimid | Lenalidomide | 100 | 2,751 | $1,830,651.69 | 13 |
| Procrit | Epoetin Alfa | 94 | 2,632 | $316,085.02 | 35 |
| Letrozole | Letrozole | 83 | 2,610 | $926.06 | 16 |
| Keytruda | Pembrolizumab | 80 | 1,708 | $852,975.16 | 11 |
| Hydroxyurea | Hydroxyurea | 73 | 2,405 | $739.39 | 20 |
| Folic Acid | Folic Acid | 62 | 2,160 | $88.57 | 14 |
| Prednisone | Prednisone | 61 | 1,201 | $115.39 | 14 |
| Tagrisso | Osimertinib Mesylate | 59 | 1,770 | $984,455.63 | 11 |
| Acyclovir | Acyclovir | 49 | 1,510 | $345.36 | 11 |
| Xgeva | Denosumab | 45 | 1,260 | $137,434.65 | — |
| Gabapentin | Gabapentin | 43 | 1,470 | $361.43 | 16 |
| Dexamethasone Sodium Phosphate | Dexamethasone Sodium Phosphate | 42 | 1,111 | $66.31 | — |
| Eliquis | Apixaban | 41 | 1,300 | $24,620.52 | — |
| Zarxio | Filgrastim-Sndz | 36 | 351 | $90,776.48 | 18 |
| Famotidine | Famotidine/Pf | 33 | 700 | $21.61 | — |
| Tamoxifen Citrate | Tamoxifen Citrate | 32 | 960 | $311.48 | — |
| Tecentriq | Atezolizumab | 30 | 630 | $309,128.30 | — |
| Granisetron Hcl | Granisetron Hcl | 23 | 483 | $235.98 | — |
| Promacta | Eltrombopag Olamine | 21 | 630 | $169,709.22 | — |
| Raloxifene Hcl | Raloxifene Hcl | 19 | 750 | $352.44 | — |
| Exemestane | Exemestane | 17 | 570 | $1,436.64 | — |
| Allopurinol | Allopurinol | 16 | 480 | $40.13 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2020-03-16NUCC Taxonomy Code: 363A00000X
A physician assistant is a person who has successfully completed an accredited education program for physician assistant, is licensed by the state and is practicing within the scope of that license. Physician assistants are formally trained to perform many of the routine, time-consuming tasks a physician can do. In some states, they may prescribe medications. They take medical histories, perform physical exams, order lab tests and x-rays, and give inoculations. Most states require that they work under the supervision of a physician.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - PHYSICIAN ASSISTANT
I20201209002690
NY
9931511300
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner - Adult Health
Career & Practice History
NPI enumerated March 16, 2020.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from April 2020 to August 2026.
NPI Administrative Meta
Other Physician Assistants in Flushing
- Bojun Ni, PA-C
- Aviva Peppard, RPA-C
- Angela Shen
- Megan Tamborino, PA-C
- Wesley Hicken, PA-C
- Stephanie Ho
Mailing Address
209 Devonshire Dr
New Hyde Park, NY 110403506
Phone: 9293415459